Kanda K - Search Results

1

Electron-equivalent dose for the effect of gadolinium neutron capture therapy on the growth of subcutaneously-inoculated Ehrlich tumor cells in mice.

Akine Y, Tokita N, Tokuuye K, Satoh M, Kobayashi T, Kanda K. Akine Y, et al. Among authors: kanda k. Jpn J Clin Oncol. 1993 Jun;23(3):145-8. Jpn J Clin Oncol. 1993. PMID: 8350487

2

Neutron-capture therapy of murine ascites tumor with gadolinium-containing microcapsules.

Akine Y, Tokita N, Tokuuye K, Satoh M, Fukumori Y, Tokumitsu H, Kanamori R, Kobayashi T, Kanda K. Akine Y, et al. Among authors: kanda k. J Cancer Res Clin Oncol. 1992;119(2):71-3. doi: 10.1007/BF01209658. J Cancer Res Clin Oncol. 1992. PMID: 1429829

3

Suppression of rabbit VX-2 subcutaneous tumor growth by gadolinium neutron capture therapy.

Akine Y, Tokita N, Tokuuye K, Satoh M, Churei H, Le Pechoux C, Kobayashi T, Kanda K. Akine Y, et al. Among authors: kanda k. Jpn J Cancer Res. 1993 Aug;84(8):841-3. doi: 10.1111/j.1349-7006.1993.tb02055.x. Jpn J Cancer Res. 1993. PMID: 8407547 Free PMC article.

4

Comparison of radiation effects of gadolinium and boron neutron capture reactions.

Tokuuye K, Tokita N, Akine Y, Nakayama H, Sakurai Y, Kobayashi T, Kanda K. Tokuuye K, et al. Among authors: kanda k. Strahlenther Onkol. 2000 Feb;176(2):81-3. doi: 10.1007/pl00002332. Strahlenther Onkol. 2000. PMID: 10697655

5

A targeting model of boron neutron-capture therapy to hepatoma cells in vivo with a boronated anti-(alpha-fetoprotein) monoclonal antibody.

Yanagië H, Fujii Y, Sekiguchi M, Nariuchi H, Kobayashi T, Kanda K. Yanagië H, et al. Among authors: kanda k. J Cancer Res Clin Oncol. 1994;120(11):636-40. doi: 10.1007/BF01245373. J Cancer Res Clin Oncol. 1994. PMID: 7525592

6

A fundamental study on hyper-thermal neutrons for neutron capture therapy.

Sakurai Y, Kobayashi T, Kanda K. Sakurai Y, et al. Among authors: kanda k. Phys Med Biol. 1994 Dec;39(12):2217-27. doi: 10.1088/0031-9155/39/12/006. Phys Med Biol. 1994. PMID: 15551549

7

Estimation of absorbed dose in the covering skin of human melanoma treated by neutron capture therapy.

Fukuda H, Kobayashi T, Hiratsuka J, Karashima H, Honda C, Yamamura K, Ichihashi M, Kanda K, Mishima Y. Fukuda H, et al. Among authors: kanda k. Pigment Cell Res. 1989 Jul-Aug;2(4):365-9. doi: 10.1111/j.1600-0749.1989.tb00222.x. Pigment Cell Res. 1989. PMID: 2798332

8

Analytical calculation of boron- 10 dosage in cell nucleus for neutron capture therapy.

Kobayashi T, Kanda K. Kobayashi T, et al. Among authors: kanda k. Radiat Res. 1982 Jul;91(1):77-94. Radiat Res. 1982. PMID: 7100396 No abstract available.

9

Human melanoma treated by boron neutron capture therapy: comparison of the clinical response with the predicted response.

Hiratsuka J, Fukuda H, Kobayashi T, Kanda K, Honda C, Ichihashi M, Mishima Y. Hiratsuka J, et al. Among authors: kanda k. Radiat Med. 1996 Sep-Oct;14(5):257-63. Radiat Med. 1996. PMID: 8988505

10

Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin.

Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M, et al. Fukuda H, et al. Among authors: kanda k. Radiat Res. 1994 Jun;138(3):435-42. Radiat Res. 1994. PMID: 8184019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

720 results

Search Page

Filters